ea0049ep1034 | Pituitary - Clinical | ECE2017
Vorotnikova Svetlana
, Skuridina Darya
, Dzeranova Larisa
, Pigarova Ekaterina
, Belaya Zhanna
Introduction: Medical therapy with dopamine agonists is the best treatment for prolactinomas of any size or invasiveness and restores ovulatory cycles in 8090% of patients. Cabergoline currently suggested nearly exclusively rather than other dopamine agonists due to its excellent tolerability and long half-life. That is why the question of safety using of this drug during pregnancy and embryo-fetal development is actual.Aim: The aim of the study is...